17.99
17.99 (0.03%)
As of Mar 06, 2024
Y-Mabs Therapeutics, Inc. [YMAB]
Source:
Company Overview
Y-Mabs Therapeutics, Inc. is a commercial-stage biopharmaceutical company focused on the development and commercialization of novel radioimmunotherapy and antibody-based therapeutic products for the treatment of cancer.
| Country | United States |
| Headquarters | new york, new york |
| Phone Number | (646)-885-8505 |
| Industry | manufacturing |
| CEO | Michael Rossi |
| Website | www.ymabs.com |